Nautus Medical (BABY) has been featured a second time at smallcapinvestor.com. From the article:
"In line with its technical breakout, Fasciocco reports that BABY recently upgraded its earnings outlook for the year. The Street, he says, now looks for profits to soar 48% to $0.69 a share from $0.47 a year ago. The stock also sells with a P/E ratio of 31, he says. Next year, analysts expect a 27% gain in net to $0.88 a share."
Insiders and institutions have been buying as well.